Insider Holders & Insider Ownership - ARROWHEAD PHARMACEUTICALS INC. (ARWR)

List of insiders holdings for ARROWHEAD PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Anzalone Christopher Richard
Chief Executive Officer
2024-02-02 17:25:504,066,774
0
4,066,774Form 4
GIVEN BRUCE D
Chief Operating Officer
2020-04-29 19:19:472,838,205
0
2,838,205Form 4
STEWART R BRUCE
Executive Chairman
2010-03-08 16:34:19872,000
0
872,000Form 4
Ekchian Leon
President
2005-11-21 15:31:29750,000
0
750,000Form 4
Kingsley Joseph Theodore III
Chief Financial Officer
2007-04-09 16:45:40600,000
0
600,000Form 4
Leone Peter Brian
VP, Strategic Bus. Initiatives
2018-10-23 19:59:55564,488
0
564,488Form 4
Lewis David L.
Chief Scientific Officer
2016-01-04 19:24:56472,500
0
472,500Form 4
O'Brien Patrick
COO and General Counsel
2024-01-05 19:58:47464,385
0
464,385Form 4
Myszkowski Kenneth Allen
Chief Financial Officer
2024-03-08 17:54:54400,600
0
400,600Form 4
KNOTT DAVID M
10% Owner
2008-02-13 15:43:14357,143
0
357,143Form 13G
PHILLIPS JAMES M JR
Secretary
2004-04-16 16:38:33300,000
0
300,000Form 4
McDonnel Paul Clayton
CFO (former)
2009-08-24 13:36:31290,000
0
290,000Form 4
RAHN LEROY T
Director
2010-03-08 16:33:33225,000
0
225,000Form 4
Hamilton James C
Chief Discovery/Trans Medicine
2024-01-17 18:32:24210,851
0
210,851Form 4
Li Zhen
Snr. VP, Chem and Non-Clin Dev
2019-01-16 20:24:20201,700
0
201,700Form 4
SWIFT ARTHUR L
CEO, Unidym Unit
2007-06-28 15:29:27200,000
0
200,000Form 3
San Martin Javier
Chief Medical Officer
2024-01-08 17:16:14198,497
0
198,497Form 4
FRYKMAN EDWARD W
Director
2018-01-03 20:06:48148,852
0
148,852Form 4
Oliver Tracie
Chief Commercial Officer
2024-01-08 17:17:32136,501
0
136,501Form 4
GIVEN DOUGLAS B
Director
2024-01-16 18:06:55129,711
0
129,711Form 4
PERRY MICHAEL S
Director
2023-12-19 15:55:01114,754
0
114,754Form 4
Hassard James
Chief Commercial Officer
2021-06-24 18:44:06105,750
0
105,750Form 4
STAMBAUGH LARRY G
CEO, Insert/Calando
2007-11-13 16:34:54100,000
0
100,000Form 3
Ferrari Mauro
Director
2024-01-16 18:06:2760,778
0
60,778Form 4
COLLIER CHARLES PATRICK
Director
2004-02-11 11:48:3150,000
0
50,000Form 3
Jacobs Edward Lee
Subsidiary CEO
2007-01-22 17:27:2350,000
0
50,000Form 3
Waddill William D.
Director
2024-01-16 18:06:3847,870
0
47,870Form 4
McKenney Charles
Director
2015-03-06 19:48:3042,220
0
42,220Form 4
Petrovich John George
Subsidiary CEO
2007-01-22 19:12:5640,474
0
40,474Form 3
De Backer Marianne
Director
2023-01-11 20:38:5035,860
0
35,860Form 4
Lu Hongbo
Director
2024-03-20 19:06:5833,680
0
33,680Form 4
Vakiener Victoria
Director
2024-01-16 18:06:1532,001
0
32,001Form 4
Ching Marshall Robert
10% Owner
2005-06-27 11:21:2428,666
0
28,666Form 4
OLUKOTUN ADEOYE Y
Director
2023-12-19 15:54:0722,854
0
22,854Form 4
Bradshaw Curt
Chief Scientific Officer
2020-11-23 17:58:540
0
0Form 4